{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:52:13Z","timestamp":1792497133148,"version":"4.5.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T00:00:00Z","timestamp":1734480000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cardiovasc Disord"],"DOI":"10.1186\/s12872-024-04427-4","type":"journal-article","created":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T12:11:50Z","timestamp":1734523910000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Polyethylene glycol loxenatide protects diabetic kidneys by inhibiting GRP78\/PERK\/eIF2\u03b1 pathway, and improves cardiac injury by suppressing TLR4\/NF-\u03baB inflammatory pathway"],"prefix":"10.1186","volume":"24","author":[{"given":"Chen","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,18]]},"reference":[{"issue":"15","key":"4427_CR1","doi-asserted-by":"publisher","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","volume":"376","author":"A Rawshani","year":"2017","unstructured":"Rawshani A, Rawshani A, Franz\u00e9n S, Eliasson B, Svensson AM, Miftaraj M, McGuire DK, Sattar N, Rosengren A, Gudbj\u00f6rnsdottir S. Mortality and cardiovascular disease in type 1 and type 2 diabetes. N Engl J Med. 2017;376(15):1407\u201318.","journal-title":"N Engl J Med"},{"issue":"12","key":"4427_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.2215\/CJN.11491116","volume":"12","author":"RZ Alicic","year":"2017","unstructured":"Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: challenges, progress, and possibilities. Clin J Am Soc Nephrol. 2017;12(12):2032\u201345.","journal-title":"Clin J Am Soc Nephrol"},{"key":"4427_CR3","doi-asserted-by":"publisher","first-page":"6657206","DOI":"10.1155\/2021\/6657206","volume":"2021","author":"J Han","year":"2021","unstructured":"Han J, Pang X, Shi X, Zhang Y, Peng Z, Xing Y. Ginkgo Biloba extract EGB761 ameliorates the extracellular matrix accumulation and mesenchymal transformation of renal tubules in diabetic kidney disease by inhibiting endoplasmic reticulum stress. Biomed Res Int. 2021;2021:6657206.","journal-title":"Biomed Res Int"},{"issue":"12","key":"4427_CR4","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1038\/s41577-019-0213-9","volume":"19","author":"MY Donath","year":"2019","unstructured":"Donath MY, Dinarello CA, Mandrup-Poulsen T. Targeting innate immune mediators in type 1 and type 2 diabetes. Nat Rev Immunol. 2019;19(12):734\u201346.","journal-title":"Nat Rev Immunol"},{"key":"4427_CR5","doi-asserted-by":"publisher","first-page":"104624","DOI":"10.1016\/j.neuint.2019.104624","volume":"133","author":"J Liu","year":"2020","unstructured":"Liu J, Wei L, Wang Z, Song S, Lin Z, Zhu J, Ren X, Kong L. Protective effect of Liraglutide on diabetic retinal neurodegeneration via inhibiting oxidative stress and endoplasmic reticulum stress. Neurochem Int. 2020;133:104624.","journal-title":"Neurochem Int"},{"key":"4427_CR6","doi-asserted-by":"publisher","first-page":"600175","DOI":"10.3389\/fphar.2020.600175","volume":"11","author":"R Zhou","year":"2020","unstructured":"Zhou R, Lin C, Cheng Y, Zhuo X, Li Q, Xu W, Zhao L, Yang L. Liraglutide alleviates hepatic steatosis and liver injury in T2MD Rats via a GLP-1R dependent AMPK pathway. Front Pharmacol. 2020;11:600175.","journal-title":"Front Pharmacol"},{"issue":"4","key":"4427_CR7","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1007\/s00125-011-2423-y","volume":"55","author":"E Favaro","year":"2012","unstructured":"Favaro E, Granata R, Miceli I, Baragli A, Settanni F, CavalloPerin P, Ghigo E, Camussi G, Zanone MM. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase\/Akt, extracellular signal-related kinase (ERK)1\/2 and cAMP\/protein kinase A (PKA) signalling pathways. Diabetologia. 2012;55(4):1058\u201370.","journal-title":"Diabetologia"},{"issue":"4","key":"4427_CR8","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.cmet.2018.03.001","volume":"27","author":"DJ Drucker","year":"2018","unstructured":"Drucker DJ. Mechanisms of action and therapeutic application of glucagon-like peptide-1. Cell Metab. 2018;27(4):740\u201356.","journal-title":"Cell Metab"},{"issue":"3","key":"4427_CR9","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/0014-5793(94)01430-9","volume":"358","author":"Y Wei","year":"1995","unstructured":"Wei Y, Mojsov S. Tissue-specific expression of the human receptor for glucagon-like peptide-I: brain, heart and pancreatic forms have the same deduced amino acid sequences. FEBS Lett. 1995;358(3):219\u201324.","journal-title":"FEBS Lett"},{"issue":"7","key":"4427_CR10","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1210\/endo.137.7.8770921","volume":"137","author":"BP Bullock","year":"1996","unstructured":"Bullock BP, Heller RS, Habener JF. Tissue distribution of messenger ribonucleic acid encoding the rat glucagon-like peptide-1 receptor. Endocrinology. 1996;137(7):2968\u201378.","journal-title":"Endocrinology"},{"issue":"10","key":"4427_CR11","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","volume":"7","author":"SL Kristensen","year":"2019","unstructured":"Kristensen SL, R\u00f8rth R, Jhund PS, Docherty KF, Sattar N, Preiss D, K\u00f8ber L, Petrie MC, McMurray JJV. Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials. Lancet Diabetes Endocrinol. 2019;7(10):776\u201385.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"4","key":"4427_CR12","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","volume":"375","author":"SP Marso","year":"2016","unstructured":"Marso SP, Daniels GH, Brown-Frandsen K, Kristensen P, Mann JF, Nauck MA, Nissen SE, Pocock S, Poulter NR, Ravn LS, et al. Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med. 2016;375(4):311\u201322.","journal-title":"N Engl J Med"},{"key":"4427_CR13","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.ijcard.2015.04.086","volume":"189","author":"JK Zhan","year":"2015","unstructured":"Zhan JK, Wang YJ, Wang Y, Tang ZY, Tan P, Huang W, Liu YS. The protective effect of GLP-1 analogue in arterial calcification through attenuating osteoblastic differentiation of human VSMCs. Int J Cardiol. 2015;189:188\u201393.","journal-title":"Int J Cardiol"},{"issue":"15","key":"4427_CR14","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1042\/CS20160061","volume":"130","author":"X Wang","year":"2016","unstructured":"Wang X, Ding Z, Yang F, Dai Y, Chen P, Theus S, Singh S, Budhiraja M, Mehta JL. Modulation of myocardial injury and collagen deposition following ischaemia-reperfusion by linagliptin and liraglutide, and both together. Clin Sci (London, England\u202f: 1979). 2016;130(15):1353\u201362.","journal-title":"Clin Sci (London, England : 1979)"},{"key":"4427_CR15","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.2147\/DMSO.S279104","volume":"13","author":"Z Wang","year":"2020","unstructured":"Wang Z, Ni X, Zhang L, Sun L, Zhu X, Zhou Q, Yang Z, Yuan H. Toll-like receptor 4 and inflammatory micro-environment of pancreatic islets in type-2 diabetes mellitus: a therapeutic perspective. Diabetes Metab Syndr Obes. 2020;13:4261\u201372.","journal-title":"Diabetes Metab Syndr Obes"},{"issue":"2","key":"4427_CR16","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/dom.12808","volume":"19","author":"BJ von Scholten","year":"2017","unstructured":"von Scholten BJ, Persson F, Rosenlund S, Hovind P, Faber J, Hansen TW, Rossing P. The effect of liraglutide on renal function: a randomized clinical trial. Diabetes Obes Metab. 2017;19(2):239\u201347.","journal-title":"Diabetes Obes Metab"},{"issue":"8","key":"4427_CR17","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","volume":"6","author":"KR Tuttle","year":"2018","unstructured":"Tuttle KR, Lakshmanan MC, Rayner B, Busch RS, Zimmermann AG, Woodward DB, Botros FT. Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial. Lancet Diabetes Endocrinol. 2018;6(8):605\u201317.","journal-title":"Lancet Diabetes Endocrinol"},{"key":"4427_CR18","doi-asserted-by":"publisher","first-page":"967","DOI":"10.3389\/fphar.2020.00967","volume":"11","author":"D Kawanami","year":"2020","unstructured":"Kawanami D, Takashi Y. GLP-1 receptor agonists in diabetic kidney disease: from clinical outcomes to mechanisms. Front Pharmacol. 2020;11:967.","journal-title":"Front Pharmacol"},{"key":"4427_CR19","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1016\/j.phrs.2018.03.004","volume":"131","author":"YK Li","year":"2018","unstructured":"Li YK, Ma DX, Wang ZM, Hu XF, Li SL, Tian HZ, Wang MJ, Shu YW, Yang J. The glucagon-like peptide-1 (GLP-1) analog liraglutide attenuates renal fibrosis. Pharmacol Res. 2018;131:102\u201311.","journal-title":"Pharmacol Res"},{"issue":"5","key":"4427_CR20","first-page":"1485","volume":"22","author":"D Yuan","year":"2018","unstructured":"Yuan D, Liu XM, Fang Z, Du LL, Chang J, Lin SH. Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress. Eur Rev Med Pharmacol Sci. 2018;22(5):1485\u201393.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"4427_CR21","doi-asserted-by":"publisher","first-page":"7277966","DOI":"10.1155\/2021\/7277966","volume":"2021","author":"L Ni","year":"2021","unstructured":"Ni L, Yuan C, Wu X. Endoplasmic reticulum stress in diabetic nephrology: regulation, pathological role, and therapeutic potential. Oxid Med Cell Longev. 2021;2021:7277966.","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4427_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/dom.14198","volume":"23","author":"Y Shuai","year":"2021","unstructured":"Shuai Y, Yang G, Zhang Q, Li W, Luo Y, Ma J, Chen D, Yang J, Wang X, Hu J, et al. Efficacy and safety of polyethylene glycol loxenatide monotherapy in type 2 diabetes patients: a multicentre, randomized, double-blind, placebo-controlled phase 3a clinical trial. Diabetes Obes Metab. 2021;23(1):116\u201324.","journal-title":"Diabetes Obes Metab"},{"key":"4427_CR23","doi-asserted-by":"publisher","first-page":"781856","DOI":"10.3389\/fphar.2021.781856","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Li Y, Zhao J, Wang C, Deng B, Zhang Q, Shi C. Protective effects and mechanisms of polyethylene glycol loxenatide against hyperglycemia and liver injury in db\/db diabetic mice. Front Pharmacol. 2021;12:781856.","journal-title":"Front Pharmacol"},{"key":"4427_CR24","doi-asserted-by":"publisher","first-page":"7958021","DOI":"10.1155\/2021\/7958021","volume":"2021","author":"Q Zhang","year":"2021","unstructured":"Zhang Q, Liu X, Sullivan MA, Shi C, Deng B. Protective effect of Yi Shen Pai Du formula against diabetic kidney injury via inhibition of oxidative stress, inflammation, and epithelial-to-mesenchymal transition in db\/db mice. Oxid Med Cell Longev. 2021;2021:7958021.","journal-title":"Oxid Med Cell Longev"},{"issue":"8","key":"4427_CR25","first-page":"4467","volume":"12","author":"P Yu","year":"2020","unstructured":"Yu P, Ma S, Dai X, Cao F. Elabela alleviates myocardial ischemia reperfusion-induced apoptosis, fibrosis and mitochondrial dysfunction through PI3K\/AKT signaling. Am J Transl Res. 2020;12(8):4467\u201377.","journal-title":"Am J Transl Res"},{"issue":"4","key":"4427_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods (San Diego, Calif). 2001;25(4):402\u20138.","journal-title":"Methods (San Diego, Calif)"},{"key":"4427_CR27","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.diabres.2018.06.008","volume":"143","author":"AJ Scheen","year":"2018","unstructured":"Scheen AJ. Cardiovascular outcome studies in type 2 diabetes: Comparison between SGLT2 inhibitors and GLP-1 receptor agonists. Diabetes Res Clin Pract. 2018;143:88\u2013100.","journal-title":"Diabetes Res Clin Pract"},{"issue":"20","key":"4427_CR28","doi-asserted-by":"publisher","first-page":"3166","DOI":"10.2174\/1389557521666210422114909","volume":"21","author":"PM Sivakumar","year":"2021","unstructured":"Sivakumar PM, Premkumar B, Prabhawathi V, Prabhakar PK. Role of GLP-1 analogs in the management of diabetes and its secondary complication. Mini Rev Med Chem. 2021;21(20):3166\u201382.","journal-title":"Mini Rev Med Chem"},{"issue":"1","key":"4427_CR29","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1152\/physrev.00045.2011","volume":"93","author":"JM Forbes","year":"2013","unstructured":"Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiol Rev. 2013;93(1):137\u201388.","journal-title":"Physiol Rev"},{"issue":"9","key":"4427_CR30","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1007\/s00125-019-4959-1","volume":"62","author":"S Eid","year":"2019","unstructured":"Eid S, Sas KM, Abcouwer SF, Feldman EL, Gardner TW, Pennathur S, Fort PE. New insights into the mechanisms of diabetic complications: role of lipids and lipid metabolism. Diabetologia. 2019;62(9):1539\u201349.","journal-title":"Diabetologia"},{"issue":"7","key":"4427_CR31","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1016\/S2213-8587(19)30192-5","volume":"7","author":"O Mosenzon","year":"2019","unstructured":"Mosenzon O, Blicher TM, Rosenlund S, Eriksson JW, Heller S, Hels OH, Pratley R, Sathyapalan T, Desouza C. Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial. Lancet Diabetes Endocrinol. 2019;7(7):515\u201327.","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"10193","key":"4427_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","volume":"394","author":"HC Gerstein","year":"2019","unstructured":"Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P, Probstfield J, Botros FT, Riddle MC, Ryd\u00e9n L, et al. Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial. Lancet (London, England). 2019;394(10193):131\u20138.","journal-title":"Lancet (London, England)"},{"issue":"9","key":"4427_CR33","doi-asserted-by":"publisher","first-page":"1556","DOI":"10.1111\/dom.14067","volume":"22","author":"AB van der Aart-van der Beek","year":"2020","unstructured":"van der Aart-van der Beek AB, van Raalte DH, Guja C, Hoogenberg K, Suchower LJ, Hardy E, Sj\u00f6str\u00f6m CD, Heerspink HJL. Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: pooled analysis of randomized active controlled clinical trials. Diabetes Obes Metab. 2020;22(9):1556\u201366.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4427_CR34","first-page":"17","volume":"17","author":"Y Fan","year":"2017","unstructured":"Fan Y, Lee K, Wang N, He JC. The role of endoplasmic reticulum stress in diabetic nephropathy. Curr DiabRep. 2017;17(3):17.","journal-title":"Curr DiabRep"},{"key":"4427_CR35","doi-asserted-by":"publisher","first-page":"8054817","DOI":"10.1155\/2021\/8054817","volume":"2021","author":"L Ni","year":"2021","unstructured":"Ni L, Yuan C. The mitochondrial-associated endoplasmic reticulum membrane and its role in diabetic nephropathy. Oxid Med Cell Longev. 2021;2021:8054817.","journal-title":"Oxid Med Cell Longev"},{"issue":"3","key":"4427_CR36","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1159\/000464118","volume":"41","author":"H Guo","year":"2017","unstructured":"Guo H, Li H, Wang B, Ding W, Ling L, Yang M, Gu Y, Niu J. Protective effects of glucagon-like peptide-1 analog on renal tubular injury in mice on high-fat diet. Cell Physiol Biochem. 2017;41(3):1113\u201324.","journal-title":"Cell Physiol Biochem"},{"key":"4427_CR37","doi-asserted-by":"publisher","first-page":"8574386","DOI":"10.1155\/2019\/8574386","volume":"2019","author":"K Feng","year":"2019","unstructured":"Feng K, Ge Y, Chen Z, Li X, Liu Z, Li X, Li H, Tang T, Yang F, Wang X. Curcumin Inhibits the PERK-eIF2\u03b1-CHOP pathway through promoting SIRT1 expression in oxidative stress-induced rat chondrocytes and ameliorates osteoarthritis progression in a rat model. Oxid Med Cell Longev. 2019;2019:8574386.","journal-title":"Oxid Med Cell Longev"},{"issue":"6","key":"4427_CR38","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.jacc.2008.10.033","volume":"53","author":"L Timmers","year":"2009","unstructured":"Timmers L, Henriques JP, de Kleijn DP, Devries JH, Kemperman H, Steendijk P, Verlaan CW, Kerver M, Piek JJ, Doevendans PA, et al. Exenatide reduces infarct size and improves cardiac function in a porcine model of ischemia and reperfusion injury. J Am Coll Cardiol. 2009;53(6):501\u201310.","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"4427_CR39","doi-asserted-by":"publisher","first-page":"e23570","DOI":"10.1371\/journal.pone.0023570","volume":"6","author":"W Bao","year":"2011","unstructured":"Bao W, Aravindhan K, Alsaid H, Chendrimada T, Szapacs M, Citerone DR, Harpel MR, Willette RN, Lepore JJ, Jucker BM. Albiglutide, a long lasting glucagon-like peptide-1 analog, protects the rat heart against ischemia\/reperfusion injury: evidence for improving cardiac metabolic efficiency. PLoS ONE. 2011;6(8):e23570.","journal-title":"PLoS ONE"},{"issue":"3","key":"4427_CR40","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1111\/dom.14598","volume":"24","author":"P Ueda","year":"2022","unstructured":"Ueda P, Wintzell V, Dahlqwist E, Eliasson B, Svensson AM, Franz\u00e9n S, Gudbj\u00f6rnsdottir S, Hveem K, Jonasson C, Melbye M, et al. The comparative cardiovascular and renal effectiveness of sodium-glucose co-transporter-2 inhibitors and glucagon-like peptide-1 receptor agonists: a Scandinavian cohort study. Diabetes Obes Metab. 2022;24(3):473\u201385.","journal-title":"Diabetes Obes Metab"},{"issue":"3","key":"4427_CR41","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.3390\/ijms23031288","volume":"23","author":"OM Belali","year":"2022","unstructured":"Belali OM, Ahmed MM, Mohany M, Belali TM, Alotaibi MM, Al-Hoshani A, Al-Rejaie SS. LCZ696 protects against diabetic cardiomyopathy-induced myocardial inflammation, ER stress, and apoptosis through Inhibiting AGEs\/NF-\u03baB and PERK\/CHOP signaling pathways. Int J Mol Sci. 2022;23(3):1288.","journal-title":"Int J Mol Sci"},{"issue":"29","key":"4427_CR42","doi-asserted-by":"publisher","first-page":"10679","DOI":"10.1073\/pnas.0403249101","volume":"101","author":"KS Michelsen","year":"2004","unstructured":"Michelsen KS, Wong MH, Shah PK, Zhang W, Yano J, Doherty TM, Akira S, Rajavashisth TB, Arditi M. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc Natl Acad Sci USA. 2004;101(29):10679\u201384.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4427_CR43","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1186\/s12933-024-02501-x","volume":"23","author":"T Fu","year":"2024","unstructured":"Fu T, Mohan M, Bose M, Brennan EP, Kiriazis H, Deo M, Nowell CJ, Godson C, Cooper ME, Zhao P, et al. Lipoxin A(4) improves cardiac remodeling and function in diabetes-associated cardiac dysfunction. Cardiovasc Diabetol. 2024;23(1):413.","journal-title":"Cardiovasc Diabetol"},{"key":"4427_CR44","doi-asserted-by":"crossref","unstructured":"Bonfioli GB, Rodella L, Metra M, Vizzardi E. GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction. Heart Fail Rev.\u00a02025;30(1):131\u20136.","DOI":"10.1007\/s10741-024-10450-6"},{"issue":"1","key":"4427_CR45","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1186\/s12872-024-04295-y","volume":"24","author":"R Yu","year":"2024","unstructured":"Yu R, Zhang Y, Wang T, Duan J, Li X. Effect of Tricin on cardiomyocyte damage caused by diabetic cardiomyopathy (DCM). BMC Cardiovasc Disord. 2024;24(1):668.","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"4427_CR46","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13098-022-00904-y","volume":"14","author":"Y Zuo","year":"2022","unstructured":"Zuo Y, Xiao T, Qiu X, Liu Z, Zhang S, Zhou N. Adiponectin reduces apoptosis of diabetic cardiomyocytes by regulating miR-711\/TLR4 axis. Diabetol Metab Syndr. 2022;14(1):131.","journal-title":"Diabetol Metab Syndr"},{"key":"4427_CR47","doi-asserted-by":"publisher","first-page":"1252942","DOI":"10.3389\/fcell.2023.1252942","volume":"11","author":"R Chai","year":"2023","unstructured":"Chai R, Ye Z, Xue W, Shi S, Wei Y, Hu Y, Wu H. Tanshinone IIA inhibits cardiomyocyte pyroptosis through TLR4\/NF-\u03baB p65 pathway after acute myocardial infarction. Front Cell Dev Biol. 2023;11:1252942.","journal-title":"Front Cell Dev Biol"},{"key":"4427_CR48","doi-asserted-by":"publisher","first-page":"175295","DOI":"10.1016\/j.ejphar.2022.175295","volume":"933","author":"B Qi","year":"2022","unstructured":"Qi B, Zheng Y, Gao W, Qi Z, Gong Y, Liu Y, Wang Y, Cheng X, Ning M, Lang Y, et al. Alpha-lipoic acid impedes myocardial ischemia-reperfusion injury, myocardial apoptosis, and oxidative stress by regulating HMGB1 expression. Eur J Pharmacol. 2022;933:175295.","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"4427_CR49","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.cell.2010.02.034","volume":"140","author":"GS Hotamisligil","year":"2010","unstructured":"Hotamisligil GS. Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell. 2010;140(6):900\u201317.","journal-title":"Cell"},{"issue":"5","key":"4427_CR50","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1002\/jcb.30401","volume":"124","author":"CB Gunner","year":"2023","unstructured":"Gunner CB, Azmoon P, Mantuano E, Das L, Zampieri C, Pizzo SV, Gonias SL. An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages. J Cell Biochem. 2023;124(5):743\u201352.","journal-title":"J Cell Biochem"},{"issue":"19","key":"4427_CR51","doi-asserted-by":"publisher","first-page":"15580","DOI":"10.1074\/jbc.M111.315218","volume":"287","author":"A Coope","year":"2012","unstructured":"Coope A, Milanski M, Arruda AP, Ignacio-Souza LM, Saad MJ, Anh\u00ea GF, Velloso LA. Chaperone insufficiency links TLR4 protein signaling to endoplasmic reticulum stress. J Biol Chem. 2012;287(19):15580\u20139.","journal-title":"J Biol Chem"}],"container-title":["BMC Cardiovascular Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12872-024-04427-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12872-024-04427-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,18]],"date-time":"2024-12-18T13:06:14Z","timestamp":1734527174000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccardiovascdisord.biomedcentral.com\/articles\/10.1186\/s12872-024-04427-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,18]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4427"],"URL":"https:\/\/doi.org\/10.1186\/s12872-024-04427-4","relation":{},"ISSN":["1471-2261"],"issn-type":[{"value":"1471-2261","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,18]]},"assertion":[{"value":"18 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved (No. 20220102\u201305) by the Union Hospital of Tongji Medical College, Huazhong University of Science and Technology. The animal care and experimental procedures were carried out in accordance with the Guidelines of the Institutional Animal Care and Use Committee of Tongji Medical College and the National Institutes of Health Guide for the Care and Use of Laboratory Animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"704"}}